937 Results for "

peripheral restriction

" in MedChemExpress (MCE) Product Catalog:
Products (937)

937 Results for "peripheral restriction" in MCE Product Catalog:

6
6 Cited Publications
Cat. No.: HY-101036
CAS No.: 87-67-2
Purity:  ≥98.0%
Choline bitartrate (Oxtriphylline) is an orally active methylxanthine-derived choline salt of theophylline. Choline bitartrate exhibits weak antihistaminic and anticholinergic activities and can enhance the effects of histamine and acetylcholine. Choline bitartrate relaxes bronchial smooth muscle, dilates coronary and peripheral blood vessels, increases urine output and electrolyte excretion, stimulates central nervous system motor activity, and induces transient hypotension following a pressor phase. Choline bitartrate modulates sleep architecture by increasing wakefulness time and reducing slow-wave sleep, without altering the frequency or severity of nocturnal hypoxemia, apnea, or hypopnea events. Choline bitartrate is used in studies of bronchospasm, nocturnal asthma, and chronic asthma .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-109108
CAS No.: 1809336-39-7
Purity:  99.68%
Synonyms: DS-3201
Research Areas:  

Cancer

Valemetostat (DS-3201), a first-in-class EZH1/2 dual inhibitor with IC50 values <10 nM. Valemetostat can be used for the research of relapsed/refractory peripheral T-cell lymphoma .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-109108A
CAS No.: 1809336-93-3
Purity:  99.84%
Synonyms: DS-3201 tosylate
Research Areas:  

Cancer

Valemetostat (DS-3201) tosylate, a first-in-class EZH1/2 dual inhibitor with IC50 values <10 nM. Valemetostat tosylate can be used for the research of relapsed/refractory peripheral T-cell lymphoma .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-15322
CAS No.: 1370261-96-3
Purity:  99.38%
Synonyms: P505-15; PRT-2607; BIIB-057
Target:  

Syk Apoptosis Caspase

Research Areas:  

Inflammation/Immunology Cancer

PRT062607 (P505-15; PRT-2607) is an orally active ATP-competitive Syk inhibitor with an IC50 value of 1 nM, and exhibits at least 80-fold selectivity over other kinases. PRT062607 blocks B cell antigen receptor-mediated activation, Fcε receptor 1-mediated basophil degranulation and microglial phagocytosis, and induces caspase-dependent apoptosis and microglial death. PRT062607 inhibits tumor growth and peripheral nerve injury-induced mechanical allodynia, and prevents neuronal loss. PRT062607 can be used in research related to rheumatoid arthritis, chronic lymphocytic leukemia, non-Hodgkin's lymphoma, neurodegenerative diseases and neuropathic pain .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-19721
CAS No.: 1235560-28-7
Target:  

Calcium Channel

Research Areas:  

Neurological Disease

ABT-639 is a novel, peripherally acting, selective T-type Ca 2+ channel blocker.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-119980
CAS No.: 69-23-8
Purity:  98.70%
Fluphenazine is a potent, orally active phenothiazine-based dopamine receptor antagonist. Fluphenazine blocks neuronal voltage-gated sodium channels. Fluphenazine acts primarily through antagonism of postsynaptic dopamine-2 receptors in mesolimbic, nigrostriatal, and tuberoinfundibular neural pathways. Fluphenazine can antagonize Methylphenidate-induced stereotyped gnawing and inhibit climbing behaviour in mice. Fluphenazine can be used for researching psychosis and painful peripheral neuropathy associated with diabetes and has potential to inhibit SARS-CoV-2 .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-13106
CAS No.: 1316755-16-4
Purity:  98.89%
Synonyms: EMA401; PD-126055; (S)-EMA400
Olodanrigan (EMA401) is a highly selective, orally active, peripherally restricted angiotensin II type 2 receptor (AT2R) antagonist. It is under development as a neuropathic pain therapeutic agent. Olodanrigan (EMA401) analgesic action appears to involve inhibition of augmented AngII/AT2R induced p38 and p42/p44 MAPK activation, and hence inhibition of DRG neuron hyperexcitability and sprouting of DRG neurons .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-A0081
CAS No.: 146-56-5
Fluphenazine dihydrochloride is a potent, orally active phenothiazine-based dopamine receptor antagonist. Fluphenazine dihydrochloride blocks neuronal voltage-gated sodium channels. Fluphenazine dihydrochloride acts primarily through antagonism of postsynaptic dopamine-2 receptors in mesolimbic, nigrostriatal, and tuberoinfundibular neural pathways. Fluphenazine dihydrochloride can antagonize Methylphenidate-induced stereotyped gnawing and inhibit climbing behaviour in mice. Fluphenazine dihydrochloride can be used for researching psychosis and painful peripheral neuropathy associated with diabetes and has potential to inhibit SARS-CoV-2 .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-19057A
CAS No.: 130466-38-5
Synonyms: MK-467 hydrochloride; L-659066 hydrochloride
Target:  

Adrenergic Receptor

Research Areas:  

Neurological Disease Endocrinology

Vatinoxan hydrochloride (MK-467 hydrochloride;L-659066 hydrochloride) is a peripheral α2 adrenergic receptor antagonist.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-101381
CAS No.: 102394-31-0
Purity:  99.93%
Synonyms: AF-DX 116
Target:  

mAChR

Otenzepad (AF-DX 116) is a selective and competitive M2 muscarinic acetylcholine receptor antagonist, with IC50 values of 640 nM and 386 nM for rabbit peripheral lung and rat heart, respectively .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-Y0850
CAS No.: 9002-89-5
Research Areas:  

Neurological Disease

Polyvinyl alcohol (Mw 146000-186000, 99+% hydrolyzed) is a non-biodegradable, hydrophilic, odorless biomedical polymer with cell adhesion/proliferation inhibition, peripheral nerve regeneration induction, dissolution enhancement, and non-toxic, biocompatible properties .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-101176
CAS No.: 93515-00-5
Purity:  ≥99.0%
Target:  

Melatonin Receptor

Research Areas:  

Cancer

2-Iodomelatonin is a potent agonist of melatonin receptor 1 (MT1) with a Ki value of 28 pM, it is more 5-fold selective for MT1 over MT2 . 2-iodomelatonin can be used to identify, characterize and localize melatonin binding sites in the brain and peripheral tissues .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-18977
CAS No.: 1380424-42-9
Target:  

MAGL

KML29 is an extremely selective, orally active and irreversible MAGL inhibitor, with IC50 values of 15 nM, 43 nM and 5.9 nM for mouse, rat and human MAGL, respectively. KML29 exhibits minimal cross-reactivity toward other central and peripheral serine hydrolases, including no detectable activity against FAAH .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16100
CAS No.: 1291779-76-4
Research Areas:  

Metabolic Disease Cancer

BI 99179, a chemical probe, is a potent and selective type I fatty acid synthase (FAS) inhibitor with an IC50 of 79 nM. BI 99179 is a tool compound suitable for the in vivo validation of FAS as a target for lipid metabolism related diseases. BI 99179 exhibits significant exposure (both peripheral and central) upon oral administration in rats .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-19057
CAS No.: 114914-42-0
Synonyms: MK-467; L-659066
Vatinoxan (MK-467) is an alpha 2-adrenergic receptor antagonist. The peripheral selectivity of Vatinoxan determines that it has limited penetration across the blood-brain barrier and therefore has low concentrations in the central nervous system. Vatinoxan antagonizes alpha 2-adrenergic receptor receptors by binding to them, thereby reducing or preventing cardiovascular effects caused by α2-adrenergic agonists. Vatinoxan can be used in studies of cardiovascular effects, sedation and analgesia .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-14229
CAS No.: 1197300-24-5
Purity:  99.71%
Synonyms: CCDC
TGR5 Receptor Agonist (CCDC), a potent Takeda G protein-coupled receptor 5 (TGR5; GPCR19) agonist, shows improved potency in the U2-OS cells and melanophore cells with pEC50s of 6.8 and 7.5, respectively. TGR5 Receptor Agonist can induce peripheral and central hypersensitivity to bladder distension in mice, and increase intracellular Ca 2+ concentration. TGR5 Receptor Agonist can also reduces food intake and improves insulin responsiveness, in diet-induced obese mice. TGR5 Receptor Agonist can be used to research diabetes, bladder hypersensitivity and anti-obesity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B1337S1
CAS No.: 61037-86-3
Choline-d9 chloride is the d9-labeled Choline chloride (HY-B1337). Choline chloride is an orally active methylxanthine derivative. Choline chloride exhibits weak antihistaminic and anticholinergic activities and potentiates the effects of histamine and acetylcholine. Choline chloride relaxes bronchial smooth muscle, dilates coronary and peripheral blood vessels, increases urine output and electrolyte excretion, stimulates locomotor activity in the central nervous system, and induces transient hypotension following a pressor phase. Choline chloride modulates sleep architecture by increasing wakefulness time and reducing slow-wave sleep, without altering the frequency or severity of nocturnal hypoxemia, apnea, or hypopnea events. Choline chloride is used in studies of bronchospasm, nocturnal asthma, and chronic asthma .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P3609
CAS No.: 228546-92-7
Synonyms: JNJ 38488502; FE 200665
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

CR 665 (JNJ 38488502) is a peripherally selective κ-opioid agonist. CR 665 can activate the kappa opioid receptor with EC50 value of 10.9 nM. CR 665 can be used for the research of peripheral pain .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P2476
CAS No.: 147450-30-4
Peripheral Myelin P0 Protein (180-199), mouse is a neuritogenic peptide. Peripheral Myelin P0 Protein (180-199), mouse induces experimental autoimmune neuritis and enhances antibody production. Peripheral Myelin P0 Protein (180-199), mouse can be used in research on Guillain-Barré syndrome and experimental autoimmune neuritis .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B0347
CAS No.: 103890-78-4
Lacidipine is an orally active and highly selective L-type calcium channel blocker that acts on smooth muscle calcium channels, primarily dilates peripheral arteries, reduces peripheral resistance, and has long-lasting anti-hypertensive activity. Lacidipine protects HKCs from apoptosis induced by ATP depletion and recovery by modulating the caspase-3 pathway. Lacidipine can be used in studies of hypertension, atherosclerosis and acute kidney injury (AKI) .
loading...
    loading...